onbrez breezhaler powder for inhalation, hard capsules
novartis farmaceutica s.a. - indacaterol (indacaterol maleate) - powder for inhalation, hard capsules - 150mcg
onbrez breezhaler powder for inhalation, capsules hard
novartis farmaceutica s.a. - indacaterol (indacaterol maleate) - powder for inhalation, capsules hard - 150mcg
ultibro breezhaler 85 micrograms/43 micrograms, inhalation powder hard capsules
novartis europharm limited - indacaterol, glycopyrronium bromide - inhalation powder, hard capsule - 110 microgram indacaterol and 50 microgram glycopyrronium - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, adrenergics in combination with anticholinergics - indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd)
onbrez breezhaler indacaterol maleate 300 microgram hard capsule for inhalation
novartis pharmaceuticals australia pty ltd - indacaterol maleate, quantity: 389 microgram (equivalent: indacaterol, qty 300 microgram) - capsule, hard - excipient ingredients: gelatin; lactose monohydrate; titanium dioxide; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; brilliant blue fcf aluminium lake; industrial methylated spirit; iron oxide black; ethanol; shellac; strong ammonia solution; sulfuric acid - onbrez breezhaler is a long-acting beta2-agonist indicated for long-term, once-daily, maintenance bronchodilator treatment of airflow limitation in patients with chronic obstructive pulmonary disease (copd).
onbrez breezhaler indacaterol maleate 150 microgram hard capsule for inhalation
novartis pharmaceuticals australia pty ltd - indacaterol maleate, quantity: 194 microgram (equivalent: indacaterol, qty 150 microgram) - capsule, hard - excipient ingredients: gelatin; lactose monohydrate; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; strong ammonia solution; ethanol absolute; iron oxide black; ethanol; shellac; sulfuric acid - onbrez breezhaler is a long-acting beta2-agonist indicated for long-term, once-daily, maintenance bronchodilator treatment of airflow limitation in patients with chronic obstructive pulmonary disease (copd).
onbrez breezhaler 150mcg inhalation powder hard capsule
novartis corporation (malaysia) sdn. bhd. - indacaterol -
onbrez breezhaler 150mcg inhalation powder hard capsule
novartis corporation (malaysia) sdn. bhd. - indacaterol -
enerzair breezhaler (indacaterol acetate/glycopyrronium bromide/mometasone furoate) 150/50/160mcg inhalation powder hard capsule
novartis corporation (malaysia) sdn. bhd. - glycopyrronium bromide; mometasone furoate; indacaterol acetate -
atectura breezhaler (indacaterol acetate/mometasone furoate) 150/80mcg inhalation powder hard capsules
novartis corporation (malaysia) sdn. bhd. - mometasone furoate; indacaterol acetate -
atectura breezhaler (indacaterol acetate/mometasone furoate) 150/160mcg inhalation powder hard capsules
novartis corporation (malaysia) sdn. bhd. - mometasone furoate; indacaterol acetate -